Pelargonium (Umckaloabo) for Sinus And Congestion Relief

Research suggests that Pelargonium sidoides extract EPs 7630 (Umckaloabo) has meaningful clinical support for relieving sinus-related symptoms, with evidence drawn from multiple randomized controlled trials, systematic reviews, meta-analyses, and prospective studies consistently pointing in the same direction. Studies indicate that EPs 7630 outperforms placebo in reducing sinusitis severity scores, nasal obstruction, and facial pain in both acute bacterial and post-viral rhinosinusitis, and a 2023 network meta-analysis of 47 randomized controlled trials ranked Pelargonium sidoides among the top-performing herbal medicines for common cold symptoms and acute post-viral rhinosinusitis specifically. A 2024 real-world cohort study further suggested longer-term benefits, including reduced recurrence and lower antibiotic use, while mechanistic research points to immunomodulatory and anti-inflammatory effects as plausible explanations for these outcomes. That said, most reviewers note that individual studies tend to be relatively small, that larger and longer follow-up trials are still needed before definitive conclusions can be drawn, and that as with any botanical preparation, potential interactions and side effects warrant consideration.